Yuqing Sun
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Dual-targeted 68 Ga-NOTA-3P-TATE-RGD PET/CT in Radioactive-iodine Negative Differentiated Thyroid Cancer : An Exploratory Comparative Study With 18 F-FDG.
Journal: Clinical nuclear medicine
Published: December 10, 2025
Camrelizumab and apatinib in Chinese patients with locally advanced or metastatic radioiodine-refractory differentiated thyroid cancer: an exploratory open-label, single-arm trial.
Journal: BMC medicine
Published: August 18, 2025
Anlotinib in progressive RAI-refractory differentiated thyroid cancer: long-term results and PET/CT prognostic markers.
Journal: Endocrine-related cancer
Published: January 29, 2025
Reflective analysis on the current 131I adjuvant therapy indications in intermediate- and high-risk differentiated thyroid cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 05, 2024
BRAFV600E mutation is associated with better prognoses in radioactive iodine refractory thyroid cancer patients treated with multi-kinase inhibitors: a retrospective analysis of registered clinical trials.
Journal: Thyroid research
Published: October 27, 2024
Distinctive role of DICER1 mutations in distant metastatic thyroid cancer.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: August 12, 2024
Prognostic value of postoperative anti-thyroglobulin antibody in patients with differentiated thyroid cancer.
Journal: Frontiers in endocrinology
Published: December 12, 2023
AEBP1 promotes papillary thyroid cancer progression by activating BMP4 signaling.
Journal: Neoplasia (New York, N.Y.)
Published: November 06, 2023
Early Structural, Biochemical, and Metabolic Responses to Anlotinib in Patients With Progressive Radioactive Iodine Refractory Differentiated Thyroid Cancer.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: October 15, 2023
Risk stratification for radioactive iodine refractoriness using molecular alterations in distant metastatic differentiated thyroid cancer.
Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
Published: September 12, 2023
Characterizing Genetic Alterations Related to Radioiodine Avidity in Metastatic Thyroid Cancer.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 09, 2023
Fusion Oncogenes in Patients With Locally Advanced or Distant Metastatic Differentiated Thyroid Cancer.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 31, 2023
Last Updated: 09/26/2026